Adverse effects of dopamine potentiation by long-term treatment with selegiline
A patient with triosephosphate isomerase (TPI) deficiency exhibited worsening of abnormal involuntary movements of the dystonic type and developed psychiatric symptoms while on selegiline. When selegiline was stopped after 9 years of treatment, abnormal involuntary movements improved to pretreatment...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2004
|
| Sorozat: | MOVEMENT DISORDERS
19 No. 1 |
| doi: | 10.1002/mds.10641 |
| mtmt: | 1032213 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/10113 |